| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | |
| Balance Sheet Date | 2026-Apr-30 | 2026-Jan-31 | 2025-Oct-31 | 2025-Jul-31 | 2025-Apr-30 | 2025-Jan-31 | |||||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2026 | Q3-FY2026 | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | |||||||||||||||||||||||||||||||||||||||||||
| Operating Cash Flow | (18,720,000$) | (18,366,000$) | (18,343,000$) | (26,274,000$) | (24,056,000$) | (17,997,000$) | (18,056,000$) | (17,499,000$) | |||||||||||||||||||||||||||||||||||||||||
| Investing Cash Flow | (172,706,000$) | (14,919,000$) | (7,420,000$) | (8,232,000$) | (7,404,000$) | (4,450,000$) | (4,420,000$) | (7,034,000$) | |||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | 9,664,000$ | 9,797,000$ | 7,265,000$ | 8,166,000$ | 7,389,000$ | 4,063,000$ | 4,447,000$ | 7,037,000$ | |||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | (185,000$) | 149,182,000$ | (27,000$) | (1,875,000$) | 214,703,000$ | (119,000$) | (575,000$) | 116,253,000$ | |||||||||||||||||||||||||||||||||||||||||
| End Cash Position | 99,710,000$ | 291,321,000$ | 175,424,000$ | 201,214,000$ | 237,595,000$ | 54,352,000$ | 76,918,000$ | 99,969,000$ | 8,249,000$ | ||||||||||||||||||||||||||||||||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (28,384,000$) | (28,163,000$) | (25,608,000$) | (34,440,000$) | (31,445,000$) | (22,060,000$) | (22,503,000$) | (24,536,000$) | |||||||||||||||||||||||||||||||||||||||||